XML 39 R92.htm IDEA: XBRL DOCUMENT v3.19.3
PARENT COMPANY FINANCIAL STATEMENTS (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
ASSETS [Abstract]                                      
Cash and cash equivalents $ 126,545     $ 99,977 $ 99,977     $ 1,267,586 $ 1,267,586     $ 773,830 $ 126,545 $ 99,977 $ 773,830 $ 126,545 $ 99,977 $ 1,267,586 $ 773,830
Investment securities held to maturity, at cost                               127,582 163,893    
Other assets                               54,832 35,090    
Total assets                               6,182,890 5,835,067 5,228,332  
LIABILITIES [Abstract]                                      
Long-term borrowings                               215,838 88,963    
Other liabilities                               130,656 133,838    
Total liabilities                               5,338,932 5,087,341    
STOCKOLDERS' EQUITY [Abstract]                                      
Common stock                               378 393    
Additional paid-in capital                               580,826 565,811    
Retained earnings                               252,813 213,048    
Accumulated other comprehensive income (loss)                               6,339 (33,111)    
Treasury stock, at cost                               (445) (1,989)    
Total equity attributable to parent                               839,911 744,152    
Noncontrolling interest                               4,047 3,574    
Total stockholders' equity                               843,958 747,726 434,496 334,975
Total liabilities and stockholders’ equity                               6,182,890 5,835,067    
CONDENSED STATEMENTS OF OPERATIONS [Abstract]                                      
Interest expense 15,211 $ 14,664 $ 16,944 14,704 11,665 $ 5,693 $ 5,966 4,661 4,461 $ 3,918 $ 3,752 2,742 61,522 27,985 14,873        
Other expense                         333,160 228,232 199,663        
Income tax (benefit) expense (Includes $184, ($2,330), and ($185) reclassified from accumulated other comprehensive income (loss) for the fiscal years ended September 30, 2019, 2018 and 2017, respectively)                         (3,374) 5,117 10,233        
Net income attributable to parent 20,195 $ 29,291 $ 32,120 15,398 8,722 $ 6,792 $ 31,436 4,670 1,744 $ 9,787 $ 32,142 1,244 97,004 51,620 44,917        
Cash flows from operating activities:                                      
Net income                         101,316 52,293 44,917        
Adjustments to reconcile net income to net cash provided by (used in) operating activities [Abstract]                                      
Depreciation, amortization and accretion, net                         55,149 37,722 45,048        
Stock compensation                         12,942 11,123 10,393        
Other assets                         (5,427) 2,633 (23,408)        
Net cash provided by operating activities                         191,012 137,755 119,990        
Cash flows from investing activities:                                      
Held to Maturity: Proceeds from maturities and principal repayments                         164,044 162,118 126,420        
Net cash used in investing activities                         (339,198) (389,790) (700,433)        
Cash flows from financing activities:                                      
Cash dividends paid                         (7,760) (5,736) (4,839)        
Short-term borrowings                         0 (11,642) 0        
Long-term borrowings                         0 (258) 0        
Contingent consideration - equity                         0 0 (17,253)        
Exercise of stock options & issuance of common stock                         44 148 650        
Issuance of restricted stock                         3 4 12        
Shares repurchased for tax withholdings on stock compensation                         (49,912) (2,598) (470)        
Net cash provided by (used in) financing activities                         174,876 (915,577) 1,074,199        
Net change in cash and cash equivalents                         26,568 (1,167,609) 493,756        
CASH AND CASH EQUIVALENTS                                      
Cash and cash equivalents at beginning of fiscal year       99,977       1,267,586       773,830 99,977 1,267,586 773,830        
Cash and cash equivalents at end of fiscal year 126,545       99,977       1,267,586       126,545 99,977 1,267,586        
Meta Financial                                      
ASSETS [Abstract]                                      
Cash and cash equivalents 8,111     28,209 28,209     14,569 14,569     15,716 8,111 14,569 14,569 8,111 28,209 $ 14,569 $ 15,716
Investment securities held to maturity, at cost                               411 411    
Investment in subsidiaries                               933,196 823,215    
Other assets                               159 124    
Total assets                               941,877 851,959    
LIABILITIES [Abstract]                                      
Long-term borrowings                               87,305 87,152    
Other liabilities                               10,614 17,081    
Total liabilities                               97,919 104,233    
STOCKOLDERS' EQUITY [Abstract]                                      
Common stock                               378 393    
Additional paid-in capital                               580,826 565,811    
Retained earnings                               252,813 213,048    
Accumulated other comprehensive income (loss)                               6,339 (33,111)    
Treasury stock, at cost                               (445) (1,989)    
Total equity attributable to parent                               839,911 744,152    
Noncontrolling interest                               4,047 3,574    
Total stockholders' equity                               843,958 747,726    
Total liabilities and stockholders’ equity                               $ 941,877 $ 851,959    
CONDENSED STATEMENTS OF OPERATIONS [Abstract]                                      
Interest expense                         5,296 5,061 4,959        
Other expense                         1,044 663 440        
Total expense                         6,340 5,724 5,399        
Gain (Loss) before income taxes and equity in undistributed net income of subsidiaries                         (6,340) (5,724) (5,399)        
Income tax (benefit) expense (Includes $184, ($2,330), and ($185) reclassified from accumulated other comprehensive income (loss) for the fiscal years ended September 30, 2019, 2018 and 2017, respectively)                         (1,374) (1,504) (1,935)        
Gain (Loss) before equity in undistributed net income of subsidiaries                         (4,966) (4,220) (3,464)        
Equity in undistributed net income of subsidiaries                         101,970 55,840 48,381        
Net income attributable to parent                         97,004 51,620 44,917        
Cash flows from operating activities:                                      
Net income                         97,004 51,620 44,917        
Adjustments to reconcile net income to net cash provided by (used in) operating activities [Abstract]                                      
Depreciation, amortization and accretion, net                         153 143 136        
Equity in undistributed net income of subsidiaries                         (101,970) (55,840) (48,381)        
Stock compensation                         12,942 11,123 10,393        
Other assets                         (35) 232 7        
Accrued expenses and other liabilities                         (6,468) (860) 16,636        
Cash dividend received                         33,980 45,315 0        
Net cash provided by operating activities                         35,606 51,733 23,708        
Cash flows from investing activities:                                      
Held to Maturity: Proceeds from maturities and principal repayments                         0 8 0        
Capital contributions to subsidiaries                         0 (20,322) (82,820)        
Net cash used in investing activities                         0 (20,314) (82,820)        
Cash flows from financing activities:                                      
Cash dividends paid                         (7,760) (5,736) (4,839)        
Short-term borrowings                         0 (11,642) 0        
Long-term borrowings                         0 (258) 0        
Purchase of shares by ESOP                         2,011 1,606 1,174        
Contingent consideration - equity                         0 0 24,142        
Exercise of stock options & issuance of common stock                         44 148 650        
Issuance of restricted stock                         3 4 12        
Issuance of commons shares due to acquisitions                         0 295,767 37,296        
Cash acquired due to acquisitions                         0 697 0        
Net increase in investment in subsidiaries                         (90) (295,767) 0        
Shares repurchased for tax withholdings on stock compensation                         (49,912) (2,598) (470)        
Net cash provided by (used in) financing activities                         (55,704) (17,779) 57,965        
Net change in cash and cash equivalents                         (20,098) 13,640 (1,147)        
CASH AND CASH EQUIVALENTS                                      
Cash and cash equivalents at beginning of fiscal year       $ 28,209       $ 14,569       $ 15,716 28,209 14,569 15,716        
Cash and cash equivalents at end of fiscal year $ 8,111       $ 28,209       $ 14,569       $ 8,111 $ 28,209 $ 14,569